drugset / Trial / NCT07137585

A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity

NCT07137585

Phase 1 Active not recruiting 30 enrolled Hoffmann-La Roche
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this study is to assess the effect of RO7204239 on insulin sensitivity versus placebo in participants with T2DM and obesity or overweight.

Timeline

Start
2025-09-30
Primary completion
2026-09-14
Completion
2027-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject EMUGROBART Monoclonal antibody Subcutaneous